The two-stage import permit: initial approval, arrival clearance and validity
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Importation into the UAE is not a single application but a two-stage approval. The first stage settles whether this product and these entities may import at all, with an official time limit of 3 working days; the second stage settles whether this consignment can clear, with an official time limit of 2 working days. The import permit is valid for 2 months from the date of issue, and the application fee is AED 100. Several hard constraints run in parallel: the remaining shelf life at arrival must not fall below 2/3 of total shelf life, and imports from a bonded free zone additionally require a valid marketing office licence and a GSP certificate issued by EDE, with shelf life of at least 12 months.
- Stage one tests product-level and entity-level eligibility; stage two tests batch-level documentation and condition.
- Official clocks: 3 working days for the initial permit, 2 working days for clearance on arrival.
- The permit is valid 2 months from issue, at an application fee of AED 100.
- Shelf life floors: 2/3 generally, and 12 months for the bonded free zone route.
2. Legal basis
The rules below come from the current EDE service page for import permits for medical items and products, read together with the import and export permit provisions of the decree.
| Regulation | Reference | Publication | Provision | Key point |
| EDE service page: import permit for medical items and products | Service page, no reference number | Currently published on the EDE website | Time limits and fees | Initial import 3 working days, clearance on arrival 2 working days; application fee AED 100; validity 2 months |
| EDE service page: import permit for medical items and products | Service page, no reference number | Currently published on the EDE website | Conditions | Remaining shelf life at arrival no less than 2/3 of total shelf life; bonded free zones require a marketing office licence, a GSP certificate and shelf life of at least 12 months |
| EDE service page: import permit for medical items and products | Service page, no reference number | Currently published on the EDE website | Special products | Biological or blood, plasma or human tissue containing products need an EDE batch release certificate; radioactive materials need FANR approval; animal-origin gelatin needs an EDQM suitability certificate |
| Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical Establishments | Federal Decree-Law No. 38/2024 | Issued 1 October 2024, effective 2 January 2025 | Articles 31, 32 and 33 | The import and export permit system and the circumstances of its revocation |
3. Expert insights
Insight 1: the essence of splitting the two stages is the separation of product-level qualification from batch-level compliance. The first stage examines the marketing authorisation, the eligibility of the importing entities, and whether the product is allowed to enter; the second stage examines the batch certificates of this consignment, the certificates of analysis, consistency between goods and documents, and the condition of the goods. Our judgement is that the overwhelming majority of clearance delays arise in the second stage rather than the first: if a single model number, batch or packaging detail on the documents does not fully correspond to the registration information, the file is pushed back. Only by budgeting time for the two stages separately can the misjudgement of it was approved in three days be avoided.
Insight 2: the 2 month validity is the key variable when planning shipments backwards. The import permit runs from the date of issue, not from the date of arrival, which means shipment must be arranged immediately after the permit is issued. As a practical estimate, ocean freight plus document preparation usually consumes the greater part of the window. Our recommended approach is to confirm the goods are ready for shipment before applying for the permit, avoiding the situation where the permit starts its countdown before the goods are even loaded.
Insight 3: shelf life and special certificate requirements must be engaged at the production scheduling stage. The remaining shelf life at arrival must not fall below 2/3 of the total, and the bonded free zone route additionally requires at least 12 months, which is a substantive constraint for short-shelf-life IVD reagents and certain consumables. Biological-origin products need an EDE batch release certificate, radioactive materials need FANR approval, and animal-origin gelatin needs an EDQM suitability certificate; none of these three can be remedied on the spot at clearance, and all must be scheduled into the certificate application plan at production scheduling time.
4. Practical recommendations
- Split the import process into first and second stages with separate milestones: the first stage watches entity and product qualification, the second watches batch documents and goods condition.
- Submit the import permit application only after the goods are ready for shipment, so the 2 month validity does not start counting down before loading.
- Build a shelf life calculation table: derive production dates backwards from the estimated arrival date, satisfying both the 2/3 general position and the 12 month free zone position.
- For biological-origin, radioactive and animal-gelatin products, start the batch release certificate, FANR and EDQM applications at the production scheduling stage.
- Unify model, batch and packaging descriptions in the document templates so they match registration information and label artwork word for word, with a two-person check before submission.
- Retain receiving, inspection and release records for every batch as traceable evidence of import compliance under Articles 31-33.
5. Verification checklist
- □ The two-stage import process has been confirmed, with the first stage 3 working days and the second stage 2 working days scheduled separately
- □ The import permit application fee AED 100 is budgeted and paid according to the latest official published position
- □ The permit issue date and the shipping plan are aligned, without exceeding the 2 month validity
- □ Remaining shelf life at arrival has been calculated on the 2/3 basis, with the free zone route assessed separately on 12 months
- □ Special certificate application plans for biological-origin, radioactive and animal-gelatin products are scheduled into production nodes
- □ Model, batch and packaging information in document templates has been checked word for word against registration dossiers
- □ Receiving, inspection and release records for every batch are archived and retrievable
- □ Customs duty at 5% of CIF value (practical estimate) is built into the landed cost
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team coordinates local authorised representative and importer arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us